Movement Alert|IONQ Inc. Rises 6.12% in Regular Trading, Q2 Revenue Nearly Triples YoY with Multiple Catalysts

Market Focus
Aug 07

On August 7, IONQ Inc. rose 6.12% in regular trading, trading at $41.88/share, with turnover of $247 million. The rally was driven by a blowout Q2 earnings report combined with several additional positive developments.

IONQ reported Q2 revenue of $80.05 million, nearly tripling from $20.7 million a year earlier and significantly exceeding the analyst consensus estimate of $66.5 million. Adjusted loss per share came in at $0.33, better than the expected $0.35. The company simultaneously raised its full-year revenue guidance to $280 million-$290 million, above the prior range of $260 million-$270 million and the FactSet consensus of $268.6 million. Additionally, subsidiary Capella secured a contract with the U.S. National Reconnaissance Office for commercial SAR imagery services, while IonQ received a $28 million follow-on order from DARPA for its quantum positioning, navigation, and timing program.

Wedbush maintained an outperform rating with a $75 price target, calling the results further validation of commercial momentum. Morgan Stanley raised its target to $49, noting the 256-qubit system remains on track for H1 2027 with the SkyWater integration pivotal to scaling.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10